Aquestive Therapeutics Resubmits NDA For Anaphylm Sublingual Film
(RTTNews) - Aquestive Therapeutics (AQST) announced that it has resubmitted its New Drug Application to the FDA for Anaphylm sublingual film for the treatment of Type I allergic reactions, including anaphylaxis. The company said the resubmission is supported by positive topline h
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.